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Introduction
During S phase of the cell division cycle, the genome must be 
precisely duplicated, with no regions left unreplicated and no 
regions replicated more than once. Despite DNA replication   
being a target of many anti-cancer drugs, it is currently unclear 
how the program that regulates progression through S phase re-
sponds to replicative stresses. Before entering S phase, replica-
tion  origins  are  licensed  by  binding  of  MCM2-7  hexamers, 
which provide helicase activity during S phase to unwind DNA 
ahead of replication forks (Blow and Dutta, 2005; Arias and 
Walter, 2007). However, many more origins are licensed than 
are actually used in a normal S phase (Woodward et al., 2006). 
Only 10% of licensed origins normally initiate replication in 
an unperturbed S phase while the rest remain dormant. When 
replication fork progression is inhibited, dormant MCM2-7 are 
activated to initiate additional forks to ensure that all of the 
DNA in the region is eventually replicated (Santocanale et al., 
1999; Dijkwel et al., 2002; Anglana et al., 2003; Woodward   
et al., 2006; Ge et al., 2007; Gilbert, 2007; Ibarra et al., 2008; 
Doksani et al., 2009; Tuduri et al., 2010).
Existing data are consistent with the idea that activation   
of dormant origins in response to fork inhibition is a simple con-
sequence of origin activation being a stochastic event (Ge et al., 
2007; Blow and Ge, 2009). Dormant origins within an active 
replicon cluster are usually passively replicated, and thus in-
activated, by forks initiated from a neighboring origin. When 
fork progression is blocked, this inactivation of dormant origins 
is delayed, thereby increasing the likelihood that a nearby dor-
mant origin initiates. For this process to work effectively, there 
does not need to be any qualitative difference between the ori-
gins that fire and origins that remain dormant in any given cell 
(Blow and Ge, 2009), and in fact, all available evidence is con-
sistent with the idea that a random subset of origins is selected 
every S phase.
The  inhibition  of  replication  forks  also  activates  DNA 
damage checkpoint kinases (ataxia telangiectasia mutated [ATM], 
ataxia telangiectasia and rad-3–related [ATR] kinase, Chk1,   
and Chk2), which not only stabilize the forks, delay further   
progression through the cell cycle, and promote lesion repair 
(Bartek et al., 2004; Branzei and Foiani, 2005; Lambert and 
Carr, 2005), but also inhibit late origin firing (Santocanale and 
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fork speed would lead to an increase in the total number of forks in 
each cell as the result of a decrease in the termination rate. In other 
words, 200–400 µM HU, which reduced the fork speed four- to 
sixfold, should increase the total fork number by four- to sixfold 
if the rate of origin initiation within the cell was to remain un-
affected. Therefore, the observation that the total fork number 
only increased 1.7-fold in the presence of 200–400 µM HU 
(Fig. 1 b) indicates a strong suppression of overall origin initia-
tion in cells treated with HU. This decrease of total cellular   
fork number is consistent with previous studies showing that the   
intra–S checkpoint inhibits initiation at later-firing origins 
(Santocanale and Diffley, 1998; Shirahige et al., 1998; Dimitrova 
and Gilbert, 2000; Zachos et al., 2003; Bartek et al., 2004).
Previous studies have shown that HU and aphidicolin also 
activate additional dormant origins that do not fire efficiently in 
untreated cells (Ockey and Saffhill, 1976; Taylor, 1977; Anglana   
et al., 2003; Woodward et al., 2006; Ge et al., 2007; Gilbert, 
2007). Typically, an approximate doubling of fork density 
within active clusters is seen after slowing the fork speed to 
25% with 200 µM HU (Ge et al., 2007). Therefore, the inhibition 
of total cellular initiation rate occurs at the same time as there is 
an increase in the initiation of dormant origins.
One possible explanation for this behavior is that at low 
levels of replication inhibition, the activation of new replicon 
clusters is preferentially inhibited; this would allow dormant   
origins to initiate within active clusters while also reducing the 
overall cellular initiation rate (Ge et al., 2007; Gilbert, 2007). 
The 4–20 replication forks typically active in each replicon clus-
ter colocalize in individual replication factories (Jackson and 
Pombo, 1998; Berezney et al., 2000; Sadoni et al., 2004; Kitamura 
et al., 2006; Gillespie and Blow, 2010). To visualize replication 
factories, we transfected cells with GFP-PCNA and selected for 
analysis cells expressing only low levels of GFP-PCNA that 
progressed normally through S phase (unpublished data). Fig. 1 
(e and f) shows that 2 h after treating cells with 200 µM HU, the 
number of replication factories per cell decreased by 30–40%. 
Similar results were obtained when replication foci were labeled 
with Cy3-dUTP (Fig. 1 e) or with antibodies against endoge-
nous PCNA (Fig. S1 c). Although there is some variation in total 
foci number observed by these three different methods, they 
each gave a similar degree of reduction in factory number after 
HU treatment. A similar reduction in factory number was also 
observed when cells were treated with aphidicolin (Fig. S1 c).   
In addition to U2OS cells, HU reduced factory number in other 
cell lines including HFF, MRC-5, and IMR90, although the ef-
fect was not statistically significant in some transformed cell lines 
such as Saos2 (Fig. S1 d and not depicted). The weaker suppres-
sion of factory number in Saos2 cells might be because of defi-
cient DNA damage checkpoint responses in highly transformed 
cells. A recent study using high resolution microscopy also re-
ported an increase in factory number after HU treatment of MRC-5 
cells (Cseresnyes et al., 2009).
Dormant origin firing occurs within active 
replication factories
Because 200 µM HU caused a slight increase in total cellular 
fork number (Fig. 1 b) but a decrease in factory number (Fig. 1 e), 
Diffley, 1998; Shirahige et al., 1998; Dimitrova and Gilbert, 
2000; Zachos et al., 2003; Bartek et al., 2004). It is apparently 
paradoxical that replication stresses can simultaneously activate 
dormant origins but suppress overall origin initiation.
Adjacent replication origins are clustered and replicated 
together within replication factories, each of which contains one 
or more clusters of origins (Jackson and Pombo, 1998; Berezney   
et al., 2000; Sadoni et al., 2004; Kitamura et al., 2006; Gillespie 
and Blow, 2010). Different sets of replication factories are activ-
ated at different times during S phase, constituting the S phase 
temporal program of a eukaryotic genome. It has recently been 
shown in Xenopus laevis egg extract that the activation of repli-
cation factories can be regulated separately from origin activa-
tion within factories by Cdk (Gillespie and Blow, 2010; Thomson 
et al., 2010). This provides a potential mechanism that may   
allow dormant origin firing while suppressing overall levels of 
origin initiation.
In this study, we show that in response to low levels of 
replication  fork  inhibition  induced  by  hydroxyurea  (HU)  or 
aphidicolin, DNA damage checkpoint kinases (ATR and Chk1) 
preferentially inhibit the activation of new replication factories 
while allowing dormant origins to fire within the existing fac-
tories experiencing replicative stress. This redirects origin firing 
away from completely unreplicated regions of the genome and 
toward active factories, thereby minimizing the deleterious con-
sequences of replication fork stalling.
Results
Replicative stress reduces origin initiation 
and replication factory number
We first examined how the replication inhibitor HU affected ini-
tiation rates in human U2OS tissue culture cells. We measured 
fork speed 2 h after HU treatment by pulsing cells with BrdU 
and measuring the lengths of BrdU-labeled tracks by DNA fiber 
analysis. This showed that HU concentrations from 50 to 500 µM 
caused a progressive decrease in fork speed down to 15% of 
untreated levels (Fig. 1 a, open squares). In parallel, the over-
all rate of DNA replication was determined by measuring the 
incorporation into DNA of the dNTP analogue ethynyl deoxy-
uridine (EdU). 2 h after HU treatment, there was a reduction in 
cellular DNA replication rate that was similar to the reduction 
of fork speed (Fig. 1 a, closed squares). Because the rate of cel-
lular replication is determined by both the fork speed and total 
number of forks within the cell, we can estimate the relative 
number of active forks per cell by dividing the cellular replica-
tion rate by the fork speed (Fig. 1 b). This showed that 2 h after 
treatment of cells with 50–500 µM HU, the total number of 
forks remained fairly constant, rising to a slight peak of 1.7 
(relative to untreated cells) at 400 µM. Similar results were   
obtained when replication rates were measured by BrdU in-
corporation (Fig. S1, a and b) and when replication forks were 
inhibited with aphidicolin rather than HU (Fig. 1, c and d).
Forks terminate when they encounter one another, and so 
lowering fork speed will also reduce the rate at which forks ter-
minate. If the overall origin initiation program during S phase 
were to remain unaffected by HU or aphidicolin, the slowing of 1287 Chk1 inhibits replication factory activation • Ge and Blow
Figure 1.  Overall origin initiation and active replication factories is reduced by HU or aphidicolin. (a–d) U2OS cells were treated with 0–500 µM HU or 
0–0.1 µg/ml aphidicolin for 4 h before pulsing with 10 µM EdU for 30 min. (a and c, closed squares) Cellular EdU incorporation was detected by flow 
cytometry with mean and SEM calculated from three independent experiments. (a and c, open squares) DNA fiber analysis was performed on parallel 
samples to determine mean fork speed. The ratio of cellular EdU incorporation to fork speed (b and d) indicates the relative number of forks per cell.   
(e and f) U2OS cells were synchronized in early S phase by nocodazole shake off followed by incubation with thymidine for 12 h. Cells were released from 
thymidine for 1 h and treated with HU for 2 h. (e) The number of active replication factories was determined by either transfecting cells with GFP-PCNA 
24 h before synchronization or pulsing cells with Cy3-dUTP and fixing after 30 min. Mean cellular foci number and SEM were derived from >50 cells.   
(f) Representative images of factories labeled with GFP-PCNA.JCB • VOLUME 191 • NUMBER 7 • 2010   1288
cells showed prolonged colocalization between PCNA and   
Cy-dUTP foci. This is consistent with our previous observation 
that cells with a partial knockdown of MCM5 initiated signifi-
cantly fewer dormant origins than control cells after treatment 
with 200 µM HU (Ge et al., 2007).
DNA damage checkpoints suppress new 
replication factories
HU and aphidicolin activate DNA damage checkpoint kinases 
(ATR and Chk1), which have been shown in previous studies to 
inhibit the initiation of replication origins and inhibit progression 
through the S phase replication timing program (Santocanale 
and Diffley, 1998; Shirahige et al., 1998; Dimitrova and Gilbert, 
2000; Zachos et al., 2003; Bartek et al., 2004). This behavior 
would still be consistent with the activation of dormant origins 
if ATR and Chk1 preferentially inhibited initiation by reducing 
the number of active replication factories. In agreement with 
this, the decrease of replication factory number observed in syn-
chronized cells treated with HU or aphidicolin was largely pre-
vented by Chk1 siRNA or caffeine (an ATR/ATM inhibitor;   
Fig. 4, a and b; and Fig. S1, c and d). In contrast, previous DNA 
fiber analysis showed that at 200 µM HU, checkpoint kinases 
reduced origin firing in active clusters by only 11–19% (Ge et al., 
2007). We measured the rates of DNA synthesis within factories 
when the checkpoint had been abolished by Chk1 siRNA or caf-
feine, both by measuring extrusion of replicated DNA from fac-
tories (Fig. 4, c and d) or by measuring Cy3-dUTP foci intensity 
(Fig. S3). Despite a modest activation of dormant origins when 
the checkpoint was inhibited, the rates of DNA synthesis within 
factories actually decreased. This decrease is likely the result   
of fork destabilization that occurs in the absence of ATR and 
Chk1 (Dimitrova and Gilbert, 2000; Lopes et al., 2001; Tercero 
and Diffley, 2001; Zachos et al., 2003). Consistent with this   
interpretation, replication tracks were observed to shorten when 
the checkpoint was inhibited (Fig. S3). Collectively, our data 
support the idea that low levels of checkpoint kinase activity   
induced by 200 µM HU preferentially reduces the number   
of replication factories rather than inhibiting the firing of ori-
gins within existing factories. This allows the activation of dor-
mant origins as a consequence of stochastic origin firing within 
existing replication factories where forks are inhibited (Blow 
and Ge, 2009).
In principle, there are three ways that checkpoints could 
decrease factory number. The most obvious one is that the 
checkpoint directly inhibits activation of new factories. Another 
possibility is that the checkpoint promotes disassembly or aban-
donment of active factories before they have completed replica-
tion. A third possibility is that the checkpoint accelerates the 
replication of DNA within factories, so that they finish replica-
tion faster than normal. This last possibility can be dismissed 
because HU does not increase the overall rate of replication within 
factories (Figs. 2 and 3).
Therefore,  we  devised  an  assay  to  determine  whether 
checkpoint kinases reduced factory number by inhibiting new 
factory activation or by promoting abandonment of partially 
replicated factories (Fig. 5). GFP-PCNA–expressing cells were 
synchronized in early S phase and pulsed with Cy3-dUTP to   
this suggests that it caused an increase in the number of replica-
tion forks in each active factory. To confirm this, we measured 
the rate of DNA replication within individual replication facto-
ries by pulsing cells with Cy3-dUTP after HU treatment (Fig. 2,   
a and b). The mean Cy3 intensity of foci is plotted in Fig. 2 c 
(closed squares) and shows that although HU reduced the Cy3-
dUTP incorporation into individual replication foci, this reduction 
was significantly less than the inhibition of fork speed (Fig. 2 c, 
open squares). The relative number of forks within each factory 
can be derived by dividing the rate of replication within each 
factory by the fork speed. This indicates that 200–300 µM HU 
more than doubled the number of forks within each replication 
factory (Fig. 2 d). At higher HU concentrations, the number of 
forks in active factories started to decline. This is consistent 
with previous DNA fiber experiments showing that 200 µM HU 
induced dormant origin firing in clusters by about twofold, but 
at higher HU concentrations, the activation of dormant origins 
declined (Ge et al., 2007). The decrease in dormant origin initi-
ation at higher concentrations of HU is most likely the result of 
high levels of the DNA damage checkpoint inhibiting replica-
tion initiation. Similar results were obtained when replication 
foci were pulse labeled with BrdU (Fig. S2, a and b). Treating 
cells with 0.1 µg/ml aphidicolin (which inhibited fork speed to 
a similar extent as 200–300 µM HU) also activated more than 
twice the number of replication forks within each replication 
factory (Fig. 2, e and f).
As an alternative way of measuring the rate of DNA repli-
cation within individual replication factories, we investigated 
the  expulsion  of  replicated  DNA  from  factories.  Cells  were 
transfected with GFP-PCNA to mark active factories (Leonhardt   
et al., 2000; Sporbert et al., 2002) and pulsed with Cy3-dUTP to 
label replicon clusters replicated by each factory (Fig. 3 a).   
30 min after the Cy3-dUTP pulse, there was significant colocal-
ization of Cy3-dUTP and GFP-PCNA foci. The degree of co-
localization between Cy3 and GFP gradually decreased at later 
times, indicating that DNA replication within the factories was 
completed (Sporbert et al., 2002; Sadoni et al., 2004). In the 
presence of 200 µM HU, the rate of separation between Cy3-dUTP 
and GFP-PCNA foci was 58% of that in controls, whereas the 
fork speed was 25% of controls (Fig. 3, b and c). This is con-
sistent with our previous conclusion that 200 µM HU approxi-
mately doubled the number of forks per factory. It should be 
noted that the length of time taken for separation of the Cy3-dUTP 
and GFP-PCNA foci is consistent with the idea that each fac-
tory replicates the DNA from more than one replicon cluster 
(Hiratani et al., 2008; Gillespie and Blow, 2010).
To further validate our results, we reduced the availability 
of dormant origins by titrating in MCM5 siRNA to the maxi-
mum level where cells still displayed normal S phase progres-
sion,  including  a  normal  density  of  replication  forks  within 
origin clusters and normal numbers and intensities of replica-
tion foci (Fig. 3 d and not depicted). The percentage of colocal-
ization between PCNA and Cy3-dUTP foci was measured 30 
and 120 min after a Cy3-dUTP pulse (Fig. 3 e). At 120 min in 
the absence of HU, the degree of colocalization was similar   
between control and MCM5 knockdown cells. However, when 
cells were treated with 200 µM HU, the MCM5 knockdown 1289 Chk1 inhibits replication factory activation • Ge and Blow
Figure 2.  Dormant origins activated within existing replication factories in response to replicative stress. U2OS cells were synchronized in early S phase 
and treated with HU for 2 h as in Fig. 1. Cells were pulsed with Cy3-dUTP for 30 min before fixing. (a and b) Representative images of control (a) and 
200 µM HU-treated cells (b). (c–f) The intensity of individual Cy3-dUTP foci was measured and averaged in each cell. (c and e, closed squares) Analysis 
of 50 cells under each condition gave rise to the overall mean foci intensity with SEM (error bars). (c and e, open squares) The replication fork speed of 
the samples was measured by DNA fiber analysis. The ratio of mean Cy3-dUTP focus intensity to fork speed (d and f) indicates the relative number of forks 
within each replication focus.JCB • VOLUME 191 • NUMBER 7 • 2010   1290
Figure 3.  HU activates dormant origins within active replication factories. U2OS cells were synchronized in early S phase as described in Fig. 1.   
(a–c) Cells were transfected with GFP-PCNA 24 h before synchronization in early S phase. After HU treatment, cells were transfected with Cy3-dUTP and   
fixed for 30, 60, 90, or 120 min to analyze the percentage of colocalization between Cy3-dUTP (red) and GFP-PCNA foci (green). (a) Labeling scheme 
and representative images are shown. The percentage of colocalization within individual cells was calculated by dividing the colocalized volume of   
Cy3 and GFP-PCNA foci by the total volume of GFP-PCNA foci. Analysis of >40 cells gave rise to the mean percentage of colocalization at each time 
point and SEM. (b) Lines were fitted to the data points to calculate the gradient, which indicates the rate of replication within the factories. (c) Composite 
data from three independent experiments were combined to give a mean gradient and SEM between the three experiments. (d and e) U2OS cells were 
transfected with MCM5 siRNA 72 h before synchronization in early S phase. (d) Chromatin-bound MCM2 and MCM5 levels were determined by   
immunoblotting after MCM5 siRNA. After 200 µM HU treatment, cells were transfected with Cy3-dUTP and fixed for 30 or 120 min afterward. (e) The percentage 
of colocalization between Cy3-dUTP and PCNA foci (as revealed by anti-PCNA immunofluorescence) is shown.1291 Chk1 inhibits replication factory activation • Ge and Blow
(therefore becoming Cy3-only foci) with a corresponding in-
crease in the number of newly arisen PCNA-only foci. Treat-
ment with HU reduced the number of Cy3-only foci to 60% 
of control values, which is consistent with the 50–60% reduc-
tion in factory replication rates shown in Figs. 3 b and 4 b. Con-
trary to what would be expected if the checkpoint promoted 
abandonment of partially replicated factories, treatment with 
caffeine plus HU further reduced the number of Cy3-only foci 
to 30%. This reflects the even more decreased rate of DNA 
synthesis within factories in the absence of checkpoint kinases 
and is likely because of the requirement of checkpoint in stabi-
lizing replication forks (Fig. 4 b and Fig. S3). Two observations 
strongly suggest that most of the Cy3-only foci had completed 
replication and were not partially replicated foci whose forks 
had been disassembled. First, the number of Cy3-only foci in 
Fig. 5 b matches the rates of factory replication shown in Fig. 4 b, 
label active replication foci. Cells were treated with 200 µM HU 
for 2 h before analyzing the colocalization between Cy3-dUTP 
and GFP-PCNA foci. For each cell, we measured the number of 
foci  containing  colocalized  PCNA  and  Cy3-dUTP  (factories 
replicating during the Cy3-dUTP pulse that were still active 2 h 
later), the number of Cy3 foci not associated with PCNA (facto-
ries replicating at the time of the Cy3-dUTP pulse but no longer 
active 2 h later), and the number of PCNA foci not associated 
with Cy3-dUTP (factories activated only after the Cy3-dUTP 
pulse). Because the early (type II) S phase replication pattern in 
U2OS cells lasts >4 h, our experiments should measure replica-
tion dynamics within the same early stage of the replication 
timing program. This was confirmed by the PCNA-only foci 
still making up an early (type II) replication pattern 2 h after the 
Cy3-dUTP pulse (Fig. 5 a and not depicted). In untreated cells, 
around half of the existing factories finished replication in 2 h 
Figure 4.  The effect of checkpoint inhibition on replication factories. Cells were transfected with GFP-PCNA 24 h before synchronization in early S phase, 
and the DNA damage checkpoint in these cells was inhibited by either CHK1 siRNA (transfected simultaneously with GFP-PCNA) or 5 mM caffeine. (a) Total 
cell lysate was immunoblotted for phospho-Chk1, Chk1, and H3. (b) U2OS cells were synchronized in early S phase as described for Fig. 1. After release 
from thymidine for 1 h, cells were treated with 200 µM HU for 2 h in the presence or absence of caffeine. The number of GFP-PCNA foci in each cell (>50 
cells analyzed for each condition) was determined, with error bars representing SEM. (c and d) The rate of DNA replication within factories was measured 
by the protocol described in Fig. 3, but this time, comparing cells where the checkpoint was inhibited by Chk1 siRNA or caffeine. (c) Data from one set of 
experiments are shown. Analysis of >50 cells gave rise to the mean percentage of colocalization at each time point and SEM. Lines were fitted to the data 
points to calculate the gradient, which indicates the rate of replication within the factories. (d) Two independent experiments (n = 2) were performed to give 
rise to the mean gradient under each condition, and statistical significance is shown as SEM between the two gradients.JCB • VOLUME 191 • NUMBER 7 • 2010   1292
the total number of replication factories still dropped by 30–40%. 
When caffeine was added to the cells at the same time as HU, the 
number of newly activated PCNA-only foci was restored to 
65% of control levels (Fig. 5 b). Therefore, our data show that 
checkpoint kinases activated by low levels of replication stress 
inhibit new factory activation.
Previous work has shown that the regulation of S phase pro-
gression can be regulated at three distinct levels: origin activation 
within individual replication factories, activation of replication 
factories during individual stage of the replication timing program, 
and progression from one stage of the replication timing program 
to another (Krasinska et al., 2008; Gillespie and Blow, 2010; 
as would be expected if the Cy3-only foci had all completed 
replication. Second, the reduction in Cy3-only foci caused by 
HU was matched by a corresponding increase in the number of 
colocalized Cy3 and PCNA foci (Fig. 5 b, yellow bars). These 
observations suggest that no partially replicated foci had been 
abandoned. In addition, HU caused a fourfold reduction in the 
number of PCNA-only foci (newly activated foci; Fig. 5 b, 
green bars), suggesting that HU inhibited new factory activa-
tion. This fourfold inhibition of new factory activation is broadly 
in agreement with our previous measurements, which showed 
that although the replication rate in factories was reduced to 
50%, leading to a doubling of the lifetime of existing factories, 
Figure 5.  Checkpoint kinases inhibit new replication factory activation. Cells were transfected with GFP-PCNA 24 h before synchronization into early   
S phase as described for Fig. 1. After release from thymidine for 1 h, cells were pulse labeled with Cy3-dUTP followed by treatment with 200 µM HU for   
2 h in the presence or absence of caffeine. (a) Representative images of nuclei fixed at 30 (i) or 120 min (ii) after Cy3-dUTP pulse. This shows that cells were 
in the same early timing stage throughout the experiment. (b) The number of Cy3 foci colocalized with GFP-PCNA foci (>10% volume overlap), Cy3 foci 
not colocalized with GFP-PCNA foci (<10% volume overlap; Cy3-only foci), and the GFP-PCNA foci not colocalized with cy3 foci (<10% volume overlap; 
PCNA-only foci) were quantified, and their mean value per cell was represented as yellow, red, and green bars, respectively. Analysis of >50 cells gave 
rise to mean and SEM (error bars).1293 Chk1 inhibits replication factory activation • Ge and Blow
cannot rectify the problem by licensing new origins but, instead, 
can only use the origins licensed before entry into S phase.   
To overcome this limitation, an excess of origins are licensed, 
from which a small subset is selected for initiation during   
S phase, with the rest (80–95%) normally remaining dormant 
(Santocanale et al., 1999; Dijkwel et al., 2002; Anglana et al., 
2003; Woodward et al., 2006; Ge et al., 2007; Gilbert, 2007; 
Ibarra et al., 2008; Doksani et al., 2009; Tuduri et al., 2010). 
These dormant origins can be activated when replication forks 
are inhibited, probably by a simple stochastic mechanism, and 
help cells survive these replicative stresses (Woodward et al., 
2006; Ge et al., 2007; Ibarra et al., 2008; Blow and Ge, 2009; 
Kunnev et al., 2010). Cells lacking sufficient dormant origins 
are hypersensitive to replicative stress (Woodward et al., 2006; 
Ge et al., 2007; Kunnev et al., 2010), and mice with a reduced 
MCM level are cancer prone, probably because of a lack of dor-
mant origins (Pruitt et al., 2007; Shima et al., 2007; Kunnev et al., 
2010). However, little is known about how progression through 
the replication timing program and the use of dormant origins 
are regulated in response to replicative stresses. One of the   
major responses to replication fork inhibition is activation of the 
DNA damage checkpoint kinases ATM, ATR, Chk1, and Chk2 
(Bartek et al., 2004; Branzei and Foiani, 2005; Lambert and 
Carr, 2005). Among other activities, these kinases are known to 
inhibit initiation of late-firing origins and prevent progression to 
later stages of S phase (Santocanale and Diffley, 1998; Shirahige   
et al., 1998; Dimitrova and Gilbert, 2000; Zachos et al., 2003; 
Bartek et al., 2004). These checkpoint kinases must therefore 
inhibit late-firing origins while at the same time allowing acti-
vation of dormant origins.
We show that ATR and Chk1, when activated in response 
to fork inhibition, reduce the number of active replication facto-
ries. We show that this occurs by a reduction in the rate at which 
replication factories are activated. A role for Chk1 in negatively 
regulating factory activation is also supported by the observation 
that Chk1 inhibition leads to an increase in factory number in the 
absence of replication inhibition (Maya-Mendoza et al., 2007; this 
study). We also show that when replication forks are inhibited, 
most dormant origins are activated in active replication factories. 
This is consistent with the increased density of replication forks 
that is seen in replicon clusters by DNA fiber analysis (Ge et al., 
2007). Activation of dormant origins within active clusters/ 
factories is likely to occur as a direct consequence of stochastic   
origin firing (Blow and Ge, 2009). As well as inhibiting factory 
activation, ATR and Chk1 can also decrease the rate of origin   
firing in existing factories (Ge et al., 2007), but at low levels   
of replicative stress, this effect appears to be less strong than   
the inhibition of factory activation: at 200 µM HU, factory acti-
vation rate is reduced by 80%, whereas dormant origin activa-
tion within active clusters is reduced by <20%. This preferential 
inhibition of factory activation by ATR/Chk1 allows the firing of 
dormant origins in active factories in response to low levels of 
replicative stress. This response is summarized in Fig. 7 a: two 
factories are shown, the top of which fires before the bottom 
(Fig. 7 a, left), but in response to replicative stress (Fig. 7 a, right), 
checkpoints inhibit activation of the second factory while allow-
ing initiation of dormant origins in the active factory.
Thomson et al., 2010). Activation of the intra–S phase check-
point blocks progression through the replication timing program 
(Fig. S4; Dimitrova and Gilbert, 2000). However, the checkpoint-
dependent inhibition of new replication factory activation shown 
in Fig. 5 b is not simply a consequence of blocking progres-
sion through the timing program because the new factories whose   
activation is inhibited by the checkpoint are part of the same 
early type II stage of the replication timing program (Fig. 5 a and 
not depicted). Therefore, the inhibition of new factory activation 
is a direct consequence of checkpoint activation.
The inhibition of new replication factories 
is dependent on ATR-Chk1
HU and aphidicolin, the inhibitors we used in this study, primar-
ily activate ATR and Chk1 checkpoint kinases. Another DNA 
damage checkpoint pathway involves ATM and Chk2, which 
are primarily activated by double-strand DNA breaks, e.g., caused 
by ionizing radiation. Therefore, we examined the replication 
dynamics after irradiating the cells with  rays. Fig. 6 (a and b) 
shows that in contrast to HU and aphidicolin, early S phase cells 
exposed to ionizing radiation did not reduce the number of rep-
lication factories but, instead, reduced the rate of replication 
within individual factories, possibly the result of an ATM/Chk2-
induced lowering of the overall initiation rate.
We next investigated the possible mechanism by which 
ATR and Chk1 could preferentially inhibit new factory activa-
tion in response to replication stress. ATR and Chk1 inhibit the 
CDC25 phosphatases required for Cdk activation, and recent 
work using Xenopus egg extracts has demonstrated that Cdks 
play a direct role in promoting the activation of replication fac-
tories (Krasinska et al., 2008; Gillespie and Blow, 2010; Thomson 
et al., 2010). Consistent with this, Fig. 6 c shows that inhibition 
of Cdk activity by roscovitine reduced the number of active rep-
lication factories in U2OS cells. However, inhibition of factory 
activation in response to HU is unlikely to be mediated by S phase 
Cdk inhibition in U2OS cells because S phase cells treated with 
HU or aphidicolin did not significantly reduce total cellular Cdk 
activity (Fig. 6, d and e). In addition, S phase cells irradiated 
with UV light did not significantly reduce Cdk activity. These 
results suggest that ATR/Chk1 reduces factory activation rates 
by acting on other S phase regulators in addition to Cdks.
Discussion
Despite DNA replication being a major target of chemother-
apeutic drugs, remarkably little is known about how the DNA 
replication program responds to replication inhibition. Our 
work demonstrates a new way that cells respond to replication 
stress, which allows cells to activate dormant origins while si-
multaneously preventing initiation spreading into later-replicating 
regions of the genome.
To prevent rereplication of DNA, the ability to license 
new origins of replication by loading MCM2-7 must cease   
before  cells  enter  S  phase.  Origin  licensing  is  not  activated 
again until passage into anaphase of the next mitosis (Blow and 
Dutta, 2005; Arias and Walter, 2007). This means that even if 
replication forks stall or are abandoned during S phase, cells JCB • VOLUME 191 • NUMBER 7 • 2010   1294
must then phosphorylate other substrates to promote initiation 
at individual origins within the active factory. Another possibil-
ity (the “founder effect” model) is that it is difficult for Cdks to 
promote initiation at origins within inactive factories/foci, but 
when the first origin in a factory has initiated, a change propa-
gates throughout the factory that facilitates initiation at other 
origins (Gillespie and Blow, 2010; Thomson et al., 2010).
It is known that ATR/Chk1 activity delays progression from 
G2 into mitosis by promoting inhibitory phosphorylation of Cdk1 
(Bartek et al., 2004; Boutros et al., 2007; Timofeev et al., 2010). 
Very little is known about how replication factories are 
activated and regulated, so we can only speculate about how 
their activation is inhibited by ATR/Chk1. Recent studies have 
demonstrated that lowering Cdk activity can preferentially in-
hibit the activation of new replication factories (Gillespie and 
Blow, 2010; Thomson et al., 2010). Two possible explanations 
for this effect have been proposed. One possibility (the “factory 
substrate” model) is that Cdks may have specialized substrates 
within a replication factory or focus that must be phosphory-
lated to activate it; once a factory/focus has been activated, Cdks 
Figure 6.  Effect of different treatments on factory number. (a) After synchronization in early S phase as described in Fig. 1, U2OS cells were irradiated 
with 1–5 Gy  ray. 2 h after irradiation, cells were pulsed with Cy3-dUTP. Both the number and intensity of the Cy3-dUTP foci were measured in each cell. 
The mean and SEM were derived from >50 cells. (b) 2 h after irradiation with 1–5 Gy  ray or 20 J/m
2 UV in the presence or absence of 10 µM ATM 
inhibitor KU55933, total cell lysate was immunoblotted for phospho-CHK1, phospho-CHK2, and actin. (c) After synchronization in early S phase, U2OS 
cells were treated with 0–250 µM roscovitine for 2 h and pulse labeled with Cy3-dUTP. Both the number and intensity of Cy3-dUTP foci were measured 
in each cell. The mean and SEM were derived from >50 cells. (d and e) Cells were synchronized in early S phase and treated with HU or 20 J/m
2 UV.   
2 h after treatment, cells were lysed for immunoprecipitation with Cdk2 or cyclin A antibody. The associated kinase activity of the immunoprecipitates was 
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The preferential inhibition of new factory activation by 
ATR/Chk1 causes the redirection of limited replication resources 
toward active replicon clusters where forks are inhibited and 
away from regions that have yet to embark on replication. This 
ensures rapid rescue of stalled forks and minimizes the risk of 
undergoing inappropriate recombination or apoptosis (Fig. 7 b). 
This can explain why decreasing the number of dormant origins 
makes cells hypersensitive to DNA-damaging agents and makes 
mice cancer prone (Woodward et al., 2006; Ge et al., 2007; 
Pruitt et al., 2007; Shima et al., 2007; Kunnev et al., 2010). It can 
also explain why adjacent origins are organized into clusters that 
initiate simultaneously within factories, as this allows dormant ori-
gins to be activated where they are needed and also allows paus-
ing of replication by delaying activation of unreplicated clusters. 
However, we could detect no significant decrease in total levels 
of Cdk activity when S phase cells were treated with HU or UV. 
In fact, there is little evidence that in human cells, activation of 
DNA damage checkpoints causes a lowering of Cdk activity in   
S phase. Indeed, ionizing radiation has been shown to cause a 
Chk1-dependent increase in Cdk2 activity (Bourke et al., 2010), 
and Cdk2 activity has been shown to be required to maintain the 
G2/M checkpoint in response to DNA damage (Chung and Bunz, 
2010). Instead, it is likely that ATR/Chk1 directly inhibits spe-
cific Cdk substrates that are required for origin initiation (if the 
founder effect model is correct) or factory activation (if the fac-
tory substrate model is correct). Therefore, artificially lowering 
Cdk activity mimics one aspect of ATR and Chk1 activation by 
preferentially inhibiting new factory activation.
Figure 7.  Model to show how cells respond to low levels of replicative stress. (a) Two adjacent clusters of origins (factories bounded by green circles) are 
shown on a single piece of DNA (black lines). Under normal circumstances (left), the upper factory is activated slightly earlier than the factory below, and 
each initiates three origins. Under low levels of replicative stress (right), replication forks are inhibited in the earlier replicating cluster, which promotes the 
firing of dormant origins as a direct consequence of stochastic origin firing. Replicative stress activates DNA damage checkpoint kinases, which preferen-
tially inhibit the activation of the unfired later clusters/new factories. (b) A model showing two converging forks on a single piece of DNA (black lines) that 
have stalled (red bars). If a dormant origin is activated between them, replication can be rapidly rescued (left). If there is no dormant origin firing between 
the stalled forks (right), the DNA damage response can lead to recombination or induction of apoptosis.JCB • VOLUME 191 • NUMBER 7 • 2010   1296
generating the gradient of separation between Cy3 and GFP-PCNA foci 
over time. Experiments were repeated multiple times, generating SEM of   
the gradient.
New factory activation rate
Cells were transfected with GFP-PCNA plasmid, and 12 h after transfec-
tion, were synchronized into early S phase using nocodazole and thymi-
dine. Replication foci were then labeled by pulsing the cells with 83 µM 
Cy3-dUTP. Cells were treated with 200 µM HU in the presence or absence 
of caffeine for 2 h before fixation and imaging. 0.2-µm serial sections were 
taken in each cell, and 3D images of the cells were reconstructed using 
Volocity software as described in the previous paragraph. Using 10% as 
the cut-off line for colocalization between Cy3 and GFP-PCNA foci, we 
quantified the number of foci containing Cy3 and GFP-PCNA, Cy3 alone, 
and GFP-PCNA alone.
Chromatin fractionation and immunoblotting
Immunoblotting  was  performed  as  previously  described  (Ge  et  al., 
2007). To prepare chromatin samples, 10
6 cells washed with PBS were 
suspended in 2 ml cytoskeleton (CSK) buffer and incubated on ice for   
10 min. After centrifugation at 5,000 g for 5 min, the pellet was col-
lected, resuspended in CSK buffer, and incubated on ice for 10 min.   
After a second 5-min spin at 5,000 g, the resultant pellet containing 
chromatin-bound sample was washed with CSK buffer three times and 
suspended in 100 µl NuPAGE LDS sample buffer (supplemented with 5% 
2-mercaptoethanol; Invitrogen). To analyze total cellular proteins, 10
5 
cells were washed with PBS and suspended in 100 µl LDS sample buffer. 
SDS gel electrophoresis and Western blotting were performed accord-
ing to standard procedures.
H1 kinase assay
For H1 kinase assays, U2OS cells were synchronized into early S phase 
using nocodazole and thymidine. 2 h after treatment (20 J/m
2 UV; or 0.1, 
0.2, or 5 mM HU), 500,000 cells were lysed by lysis buffer (50 mM Tris 
HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, and 0.5% NP-40) and immuno-
precipitated with 2 µg Cdk2 antibody (M2; Santa Cruz Biotechnology, 
Inc.) or cyclin A antibody (ab39; Abcam). The immunoprecipitates were 
incubated with 5 µg commercially purified H1 (Millipore) in 25 µl kinase 
reaction buffer (50 mM Tris HCl, pH 7.5, 1 mM MgCl2, 1 mM DTT, 5 µM 
ATP, and 5 µCi -[
33P]ATP) for 10 min at 30°C. Samples were then ana-
lyzed by SDS-PAGE followed by autoradiography.
DNA fiber analysis
DNA fiber spreading was performed as described previously (Ge et al., 
2007). Cells were pulsed with 40 µM BrdU for different times depending 
on the concentration of inhibitor used so that labeled track lengths were 
more homogenous in size than would occur if the BrdU pulse length was 
kept constant: 0–100 µM HU, 10 min; 200 µM HU, 20 min; 400–500 
µM HU, 30 min; 0.1–0.2 µg/ml aphidicolin, 20 min; and 0.4 µg/ml 
aphidicolin, 30 min. Cells were then harvested, and DNA fiber spreads 
were  prepared  as  described  previously  (Jackson  and  Pombo,  1998). 
BrdU-labeled  tracks  were  detected  with  BrdU  anti–sheep  antibody 
(M20105S; 1:1,000; BioDesign, Inc.) using either Cy3– or Alexa Fluor 
488–conjugated donkey anti–sheep secondary antibody. Biotin-11–dUTP 
was detected using a mouse monoclonal antibody (clone BN-34; 1:1,000; 
Sigma-Aldrich)  and  an  appropriate  Cy3-conjugated  second  antibody. 
Quality control for spreading DNA was performed using 0.1 µM YOYO 
(Invitrogen)  labeling.  Fibers  were  examined  using  a  65×  microscope 
(Leica) and 100× confocal microscope (LSM 510; Carl Zeiss, Inc.). The 
mean and standard deviation of track lengths were determined by mea-
suring the length of labeled tracks that were well separated from other 
tracks (thereby minimizing the risk that they represented fusions between 
adjacent replicons).
Online supplemental material
Fig. S1 shows the HU-induced increase in the number of forks per cell 
when replication rates were measured by BrdU incorporation and the HU-
induced reduction in factory number using an anti-PCNA antibody. The 
changes in factory number are shown by different cell lines treated with 
HU. Fig. S2 shows the increase in fork number per factory when cells are 
treated with HU, as measured by BrdU incorporation. Fig. S3 shows focus 
intensity and fork speed when cells are treated with combinations of HU, 
Chk1 siRNA, and caffeine. Fig. S4 shows checkpoint-dependent inhibition 
of progression through the replication timing program in cells treated with 
200 µM HU. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201007074/DC1.
These two features work together to ensure the maintenance   
of genome stability in cells.
Many anticancer drugs target DNA replication, either di-
rectly by inhibiting replication fork progression or indirectly by 
causing damage that has its primary effects during S phase (Blow 
and Gillespie, 2008). The ability of cells to survive treatment 
with these drugs depends on the correct regulation of dormant 
origins (Woodward et al., 2006; Ge et al., 2007). Therefore, this 
study raises the possibility that if certain cancer cells are in-
capable of correctly regulating dormant origin and replication 
factory usage when under replicative stress, they would be more 
sensitive to chemotherapy drugs.
Materials and methods
Cell lines, synchronization, and siRNA
U2OS, HFF, MRC-5, IMR90, and Saos2 cells were grown in DME contain-
ing 10% fetal bovine serum, penicillin, and streptomycin. To synchronize 
cells in early S phase, cells were treated with 100 ng/ml nocodazole for 
10 h before shaking off into 5 mM thymidine for 12 h. Cells were then re-
leased from thymidine for 1 h into early S phase and treated with HU, 
aphidicolin, or 5 mM caffeine for 2 h. MCM5 and CHK1 siRNA were used 
as described previously (Ge et al., 2007). siRNA oligonucleotides (Applied 
Biosystems) were made to the following sequences: Mcm5, 5-GGAG-
GUAGCUGAUGAGGUGTT-3; and Chk1, 5-AAGCAGUCGCAGUGAA-
GAUUG-3. Control unrelated oligonucleotide was purchased from Thermo 
Fisher Scientific. Transfections were performed using Lipofectamine RNAiMAX 
(Invitrogen)  according  to  the  manufacturer’s  protocol.  For  Chk1  knock-
down, U2OS cells were transfected with 40 nM siRNA twice within 72 h.
Total cellular rate of DNA synthesis
Asynchronous cells were labeled with 10 µM EdU for 30 min and stained ac-
cording to the manufacturer’s instructions (Click-iT EdU Alexa Fluor 647 flow 
cytometry; Invitrogen). DNA was stained with 20 µg/ml 7AAD. All samples 
were analyzed using a flow cytometer (FACSCalibur; BD) and CellQuest soft-
ware (BD). To quantify EdU incorporation, the geographic mean of incorpo-
rated EdU was calculated (because the data are collected on a logarithmic 
scale), from which the overall rate of DNA synthesis was derived.
Replication foci
To label replication foci, U2OS cells were transfected with 83 µM Cy3-
dUTP using FuGENE6 transfection reagent. The cellular incorporation of 
this amount of Cy3-dUTP into replication foci could last for 60 min. Cells 
were fixed with paraformaldehyde 30 min after transfection and analyzed 
on the number and intensity of Cy3-dUTP foci. Alternatively, cells were 
pulsed with 10 µM BrdU for 20 min followed by staining with BrdU anti-
body. To label replication factories, cells were transfected with GFP-PCNA 
plasmid using Lipofectamine 2000 (0.7 µg DNA/10
6 cells); only cells ex-
pressing low levels of GFP-PCNA were selected for analysis (Leonhardt   
et al., 2000). Alternatively, endogenous PCNA was labeled with PCNA 
antibody (PC10) and Alexa Fluor 568–labeled secondary antibodies.
Image acquisition and data analysis
To image replication foci/factories in cells, a wide-field fluorescence micro-
scope (DeltaVision DV3; Applied Precision) was used to collect 0.2-µm se-
rial sections using a 100× NA 1.4 Plan Apochromat objective (Olympus). 
After deconvolution with SoftWorx (Applied Precision), 3D image stacks 
were analyzed with Volocity (PerkinElmer) where a threshold-based seg-
mentation was applied to define replication foci. The same degree of 
threshold was used across different samples to cover 90% of all visually 
defined foci in each cell. The total voxel intensity of individual focus within 
a cell was averaged to give rise to cellular focus intensity. More than 120 cells 
pooled from three sets of experiments were sampled to generate mean   
focus intensity and SEM under each condition. To calculate cellular foci num-
ber, >150 cells pooled from three sets of experiments were used to generate 
mean foci number and SEM. To analyze the percentage of colocalization 
between GFP-PCNA and Cy3-dUTP foci, the total colocalized volume was 
divided by the total volume of GFP-PCNA foci within a cell. More than   
50 cells were analyzed under each condition to give rise to the mean   
percentage of colocalization between the two types of foci and SEM,   1297 Chk1 inhibits replication factory activation • Ge and Blow
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